Company Profiles

driven by the PitchBook Platform

Axon Therapies

2014 FOUNDED
PRIVATE STATUS
Series AA LATEST DEAL TYPE
$1.3M LATEST DEAL AMOUNT
$4.7M TOTAL AMOUNT RAISED
2 INVESTORS
Description

Developer of a healthcare device designed to treat neurogenic syncope and heart failure. The company's healthcare device is based on novel neuromodulation approach, enabling heart patients to begin treatment more quickly, resulting in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
315 West 36th Street
New York, NY 10018
United States

+1 (212) 929-6600
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Axon Therapies’s full profile, request a free trial.

Axon Therapies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series AA) 26-Jun-2017 $1.3M $4.7M 000.00 Completed Startup
3. Early Stage VC (Series AA) 19-Apr-2016 000 00.00 0000 Completed Startup
2. Early Stage VC (Series AA) $1.4M $1.4M $8.88M Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Axon Therapies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series AA NV 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series AA V 0,000,000 00.000000 00.00 00 00 00 00 00.000
To view this company’s complete Cap Table request access »

Axon Therapies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Action Potential Venture Capital Venture Capital Minority 000 0000 000000 0
Coridea Accelerator/Incubator 000 0000 000000 0

You’re viewing 2 of 2 investors.

Axon Therapies Executive Team (2)

Name Title Board
Seat
Contact
Info
Howard Levin MD Co-Founder, President & Board Member
Mark Gelfand Co-Founder

You’re viewing 2 of 2 executives.

Axon Therapies Board Members (2)

Name Representing Role Since Contact
Info
Howard Levin MD Self Co-Founder, President & Board Member 000 0000
Paul LaViolette Self Board Member 000 0000

You’re viewing 2 of 2 board members.